Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer

MLA

Yan Chen, et al. “Performance of a PLK1‐based Immune Risk Model for Prognosis and Treatment Response Prediction in Breast Cancer.” Cancer Medicine, vol. 12, no. 9, May 2023, pp. 11020–39. EBSCOhost, https://doi.org/10.1002/cam4.5813.

APA

Yan Chen, Yiqing You, Qiaoling Wu, Jing Wu, Shujing Lin, Yang Sun, & Zhaolei Cui. (2023). Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer. Cancer Medicine, 12(9), 11020–11039. https://doi.org/10.1002/cam4.5813

Chicago

Yan Chen, Yiqing You, Qiaoling Wu, Jing Wu, Shujing Lin, Yang Sun, and Zhaolei Cui. 2023. “Performance of a PLK1‐based Immune Risk Model for Prognosis and Treatment Response Prediction in Breast Cancer.” Cancer Medicine 12 (9): 11020–39. doi:10.1002/cam4.5813.